1,2-dimethylhydrazine increases expression ISO RGD:1551257 6480464 1, 2-Dimethylhydrazine results in increased expression of NRP2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1551257 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of NRP2 mRNA] CTD PMID:22206623 17beta-estradiol multiple interactions ISO RGD:732191 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of NRP2 mRNA CTD PMID:30165855 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:732191 6480464 2 more ... CTD PMID:23146750 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27291303 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1551257 6480464 Tetrachlorodibenzodioxin affects the expression of NRP2 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of NRP2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NRP2 mRNA CTD PMID:32109520 , PMID:33387578 2-butoxyethanol decreases expression ISO RGD:1551257 6480464 n-butoxyethanol results in decreased expression of NRP2 mRNA CTD PMID:19812364 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:732191 6480464 3 more ... CTD PMID:23146750 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:732191 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRP2 mRNA CTD PMID:28628672 3-Nitrobenzanthrone affects expression ISO RGD:732191 6480464 3-nitrobenzanthrone affects the expression of NRP2 mRNA CTD PMID:34036453 4,4'-sulfonyldiphenol increases expression ISO RGD:1551257 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of NRP2 mRNA CTD PMID:30951980 , PMID:33297965 4-hydroxyphenyl retinamide increases expression ISO RGD:1551257 6480464 Fenretinide results in increased expression of NRP2 mRNA CTD PMID:28973697 acetamide increases expression EXP 6480464 acetamide results in increased expression of NRP2 mRNA CTD PMID:31881176 aflatoxin B1 increases methylation ISO RGD:732191 6480464 Aflatoxin B1 results in increased methylation of NRP2 polyA tail CTD PMID:30157460 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of NRP2 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:732191 6480464 Antirheumatic Agents results in decreased expression of NRP2 mRNA CTD PMID:24449571 arsane affects expression ISO RGD:732191 6480464 Arsenic affects the expression of NRP2 protein CTD PMID:24675094 arsane affects methylation ISO RGD:732191 6480464 Arsenic affects the methylation of NRP2 gene CTD PMID:25304211 arsenic atom affects expression ISO RGD:732191 6480464 Arsenic affects the expression of NRP2 protein CTD PMID:24675094 arsenic atom affects methylation ISO RGD:732191 6480464 Arsenic affects the methylation of NRP2 gene CTD PMID:25304211 arsenite(3-) increases expression ISO RGD:1551257 6480464 arsenite results in increased expression of NRP2 mRNA CTD PMID:33053406 benzo[a]pyrene increases methylation ISO RGD:732191 6480464 Benzo(a)pyrene results in increased methylation of NRP2 3' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:732191 6480464 Benzo(a)pyrene affects the methylation of NRP2 intron, Benzo(a)pyrene affects the methylation of NRP2 polyA tail CTD PMID:30157460 benzo[e]pyrene increases methylation ISO RGD:732191 6480464 benzo(e)pyrene results in increased methylation of NRP2 intron, benzo(e)pyrene results in increased methylation of NRP2 polyA tail CTD PMID:30157460 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of NRP2 mRNA CTD PMID:25181051 , PMID:34947998 bisphenol A increases methylation ISO RGD:732191 6480464 bisphenol A results in increased methylation of NRP2 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:1551257 6480464 bisphenol A results in increased expression of NRP2 mRNA CTD PMID:30951980 more ... bisphenol A increases expression ISO RGD:732191 6480464 bisphenol A results in increased expression of NRP2 mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO RGD:732191 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRP2 mRNA CTD PMID:28628672 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of NRP2 mRNA CTD PMID:30816183 bisphenol F increases expression ISO RGD:1551257 6480464 bisphenol F results in increased expression of NRP2 mRNA CTD PMID:30951980 calcitriol decreases expression ISO RGD:732191 6480464 Calcitriol results in decreased expression of NRP2 mRNA CTD PMID:16002434 calcitriol increases expression ISO RGD:732191 6480464 Calcitriol results in increased expression of NRP2 mRNA CTD PMID:16002434 CGP 52608 multiple interactions ISO RGD:732191 6480464 CGP 52608 promotes the reaction [RORA protein binds to NRP2 gene] CTD PMID:28238834 chloroprene decreases expression ISO RGD:1551257 6480464 Chloroprene results in decreased expression of NRP2 mRNA CTD PMID:23125180 chlorthalidone decreases expression EXP 6480464 Chlorthalidone results in decreased expression of NRP2 mRNA CTD PMID:20625077 cisplatin increases expression ISO RGD:732191 6480464 Cisplatin results in increased expression of NRP2 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:732191 6480464 [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of NRP2 mRNA CTD PMID:30871063 cobalt dichloride decreases expression ISO RGD:732191 6480464 cobaltous chloride results in decreased expression of NRP2 mRNA CTD PMID:19320972 cocaine increases expression EXP 6480464 Cocaine results in increased expression of NRP2 mRNA CTD PMID:15691709 crocidolite asbestos decreases expression ISO RGD:732191 6480464 Asbestos, Crocidolite results in decreased expression of NRP2 mRNA CTD PMID:18687144 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of NRP2 mRNA CTD PMID:18632792 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of NRP2 mRNA CTD PMID:23640034 dexamethasone multiple interactions ISO RGD:732191 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRP2 mRNA CTD PMID:28628672 dibutyl phthalate increases expression ISO RGD:1551257 6480464 Dibutyl Phthalate results in increased expression of NRP2 mRNA CTD PMID:17361019 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in increased expression of NRP2 mRNA CTD PMID:18636392 dicrotophos increases expression ISO RGD:732191 6480464 dicrotophos results in increased expression of NRP2 mRNA CTD PMID:28302478 dorsomorphin multiple interactions ISO RGD:732191 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:732191 6480464 Doxorubicin results in decreased expression of NRP2 mRNA CTD PMID:29803840 doxorubicin increases expression ISO RGD:732191 6480464 Doxorubicin results in increased expression of NRP2 mRNA CTD PMID:30031762 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of NRP2 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:732191 6480464 entinostat results in increased expression of NRP2 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:732191 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA CTD PMID:27188386 ethanol multiple interactions ISO RGD:732191 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of NRP2 mRNA CTD PMID:23378141 ethanol multiple interactions ISO RGD:1551257 6480464 Ethanol affects the expression of and affects the splicing of NRP2 mRNA CTD PMID:30319688 ethanol affects expression ISO RGD:1551257 6480464 Ethanol affects the expression of NRP2 mRNA CTD PMID:30319688 ethanol increases expression ISO RGD:1551257 6480464 Ethanol results in increased expression of NRP2 mRNA CTD PMID:30319688 folic acid multiple interactions ISO RGD:732191 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of NRP2 mRNA CTD PMID:23378141 folic acid decreases expression ISO RGD:732191 6480464 Folic Acid results in decreased expression of NRP2 mRNA CTD PMID:21867686 folic acid multiple interactions ISO RGD:1551257 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of NRP2 mRNA] CTD PMID:22206623 folic acid increases expression ISO RGD:1551257 6480464 Folic Acid results in increased expression of NRP2 mRNA CTD PMID:25629700 fonofos increases methylation ISO RGD:732191 6480464 Fonofos results in increased methylation of NRP2 promoter CTD PMID:22847954 furan increases methylation EXP 6480464 furan results in increased methylation of NRP2 gene CTD PMID:22079235 furan decreases expression ISO RGD:1551257 6480464 furan results in decreased expression of NRP2 mRNA CTD PMID:24183702 genistein affects expression ISO RGD:732191 6480464 Genistein affects the expression of NRP2 mRNA CTD PMID:16399490 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of NRP2 mRNA CTD PMID:33387578 hydroquinone O-beta-D-glucopyranoside increases expression ISO RGD:732191 6480464 Arbutin results in increased expression of NRP2 mRNA CTD PMID:17103032 indometacin multiple interactions ISO RGD:732191 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRP2 mRNA CTD PMID:28628672 kainic acid affects response to substance ISO RGD:1551257 6480464 NRP2 protein affects the susceptibility to Kainic Acid CTD PMID:18657176 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of NRP2 mRNA CTD PMID:28801915 methapyrilene increases methylation ISO RGD:732191 6480464 Methapyrilene results in increased methylation of NRP2 intron, Methapyrilene results in increased methylation of NRP2 polyA tail CTD PMID:30157460 methylmercury chloride increases expression ISO RGD:732191 6480464 methylmercuric chloride results in increased expression of NRP2 mRNA CTD PMID:23179753 more ... methylmercury chloride multiple interactions ISO RGD:732191 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA CTD PMID:27188386 Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of NRP2 mRNA CTD PMID:21515302 N-acetylsphingosine multiple interactions ISO RGD:732191 6480464 sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of NRP2 mRNA] CTD PMID:15741222 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of NRP2 mRNA CTD PMID:28801915 nickel atom increases expression ISO RGD:732191 6480464 Nickel results in increased expression of NRP2 mRNA CTD PMID:24768652 nickel sulfate increases expression ISO RGD:732191 6480464 nickel sulfate results in increased expression of NRP2 mRNA CTD PMID:16780908 nickel sulfate decreases expression ISO RGD:732191 6480464 nickel sulfate results in decreased expression of NRP2 mRNA CTD PMID:18832182 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in increased expression of NRP2 mRNA CTD PMID:18636392 p-menthan-3-ol decreases expression ISO RGD:732191 6480464 Menthol results in decreased expression of NRP2 mRNA CTD PMID:26760959 panobinostat multiple interactions ISO RGD:732191 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA CTD PMID:27188386 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of NRP2 mRNA CTD PMID:33387578 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of NRP2 mRNA CTD PMID:32680482 parathion increases methylation ISO RGD:732191 6480464 Parathion results in increased methylation of NRP2 promoter CTD PMID:22847954 pentetrazol affects response to substance ISO RGD:1551257 6480464 NRP2 protein affects the susceptibility to Pentylenetetrazole CTD PMID:18657176 phenobarbital affects expression ISO RGD:1551257 6480464 Phenobarbital affects the expression of NRP2 mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:732191 6480464 Phenylmercuric Acetate results in increased expression of NRP2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:732191 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA CTD PMID:27188386 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of NRP2 mRNA CTD PMID:12832660 pirinixic acid increases expression ISO RGD:1551257 6480464 pirinixic acid results in increased expression of NRP2 mRNA CTD PMID:18301758 more ... procymidone decreases expression EXP 6480464 procymidone results in decreased expression of NRP2 mRNA CTD PMID:15686871 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of NRP2 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:732191 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:732191 6480464 Silicon Dioxide results in decreased expression of NRP2 mRNA CTD PMID:25351596 sodium arsenate decreases expression ISO RGD:1551257 6480464 sodium arsenate results in decreased expression of NRP2 mRNA CTD PMID:21795629 sodium arsenite affects methylation ISO RGD:732191 6480464 sodium arsenite affects the methylation of NRP2 gene CTD PMID:28589171 sphingosine 1-phosphate multiple interactions ISO RGD:732191 6480464 sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of NRP2 mRNA], sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of NRP2 mRNA] CTD PMID:15741222 succimer multiple interactions ISO RGD:1551257 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NRP2 mRNA CTD PMID:26378955 sunitinib increases expression ISO RGD:732191 6480464 Sunitinib results in increased expression of NRP2 mRNA CTD PMID:31533062 tamoxifen increases expression ISO RGD:1551257 6480464 Tamoxifen results in increased expression of NRP2 mRNA CTD PMID:25123088 terbufos increases methylation ISO RGD:732191 6480464 terbufos results in increased methylation of NRP2 promoter CTD PMID:22847954 Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of NRP2 mRNA CTD PMID:21515302 tetrachloromethane affects expression ISO RGD:1551257 6480464 Carbon Tetrachloride affects the expression of NRP2 mRNA CTD PMID:17484886 thalidomide multiple interactions ISO RGD:732191 6480464 sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of NRP2 mRNA] CTD PMID:15741222 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of NRP2 mRNA CTD PMID:23411599 , PMID:34492290 trichloroethene increases expression ISO RGD:1551257 6480464 Trichloroethylene results in increased expression of NRP2 mRNA CTD PMID:25549359 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of NRP2 gene CTD PMID:27618143 trichostatin A increases expression ISO RGD:732191 6480464 trichostatin A results in increased expression of NRP2 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:732191 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA CTD PMID:27188386 triptonide decreases expression ISO RGD:1551257 6480464 triptonide results in decreased expression of NRP2 mRNA CTD PMID:33045310 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of NRP2 mRNA CTD PMID:21515302 troglitazone decreases expression ISO RGD:1551257 6480464 troglitazone results in decreased expression of NRP2 mRNA CTD PMID:28973697 valproic acid affects expression ISO RGD:732191 6480464 Valproic Acid affects the expression of NRP2 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:732191 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:732191 6480464 Valproic Acid results in increased expression of NRP2 mRNA CTD PMID:23179753 more ... valproic acid decreases expression ISO RGD:732191 6480464 Valproic Acid results in decreased expression of NRP2 mRNA CTD PMID:24935251 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of NRP2 mRNA CTD PMID:15686871 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of NRP2 mRNA CTD PMID:19015723 vorinostat increases expression ISO RGD:732191 6480464 vorinostat results in increased expression of NRP2 mRNA CTD PMID:26272509 vorinostat multiple interactions ISO RGD:732191 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA CTD PMID:27188386 zinc atom multiple interactions ISO RGD:732191 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of NRP2 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:732191 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of NRP2 mRNA CTD PMID:18593933